DGAT1 and astrocytoma (excluding glioblastoma): To investigate the SOAT1-dependency of ZIKV in other neural cell types, we next infected astrocytoma (1321N1) and neuroblastoma cells (SH-SY5Y) and treated them with DGAT and SOAT1 inhibitors.